Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus?

C. Tortajada, J. Martínez-Lacasa, F. Sánchez, A. Jiménez-Fuentes, M. L. De Souza, J. F. García, J. A. Martínez, J. A. Caylà

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus?'. Together they form a unique fingerprint.

Medicine & Life Sciences